Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
180 Life Sciences Forms Ethereum Reserve, Raises $425 Million

180 Life Sciences Forms Ethereum Reserve, Raises $425 Million

BitcoininfonewsBitcoininfonews2025/07/29 21:05
By:Bitcoininfonews
What to Know:
  • 180 Life Sciences raises $425M to create Ethereum reserve.
  • SHIFTING focus from biotechnology to cryptocurrency treasury.
  • ETH exclusively chosen for new reserve strategy.
180 Life Sciences Forms Ethereum Reserve, Raises $425 Million

180 Life Sciences Corp. announces a $425 million private placement to build an Ethereum reserve, rebranding as ETHZilla Corporation, signaling a pivot from biopharmaceuticals to cryptocurrency.

This strategic shift could influence how traditional companies view cryptocurrency treasuries, potentially impacting ETH’s market position and inspiring similar moves in the corporate sector.

180 Life Sciences Corp. announced a $425 million private placement aimed at creating an Ethereum reserve and rebranding as ETHZilla, signifying a shift towards cryptocurrency.

The move underscores a significant corporate pivot into crypto, aligning from traditional biopharmaceuticals to asset diversification in Ethereum.

$425 Million Ethereum Reserve Initiative by ETHZilla

180 Life Sciences Corp., previously focused on biopharmaceutical research, has decided to transform its financial strategy. The company secured $425 million through a private placement , intending to establish a robust Ethereum reserve.

Leadership changes accompany this strategic shift, with the rebranding to ETHZilla Corporation led by a digital asset consortium. According to the company, “The leadership of our consortium of digital asset experts will guide us as we enter this new and exciting phase.” The consortium details, however, remain undisclosed in official reports.

Exclusive Ethereum Strategy Ignites Crypto Conversations

The decision to allocate all funds to Ethereum (ETH) signals potential market reverberations, especially if similar companies follow suit. The move deviates from traditional corporate reserves alignment.

Financial analysts note the absence of allocation to Bitcoin or other cryptocurrencies . This singular focus on ETH could influence industry trends toward specialized crypto asset reserves.

Corporate Shift Mirrors Tesla and MicroStrategy’s Crypto Moves

In the past, companies like Tesla and MicroStrategy have invested heavily in Bitcoin, but the scale of ETH investment seen here is unique. It may set a precedent for similar corporate strategies.

This ETH focus reflects changing corporate attitudes toward digital assets. While unprecedented, the move raises questions about broader market impacts and potential volatility in asset valuations.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!